TOI Boosts Positivity With Strong Q1 Results and New Leadership

The Oncology Institute (TOI) shares are trading higher after reporting a 10.3% revenue increase in Q1 2025 and reaffirming strong fiscal year guidance, alongside the appointment of Dr. Jeffrey Langsam as Chief Clinical Officer.